blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2789332

EP2789332 - PHARMACEUTICAL COMPOSITION COMPRISING DIAMINODIPHENYLSULFONE OR THE PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH DECREASE IN BONE MASS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  13.05.2016
Database last updated on 03.10.2024
Most recent event   Tooltip13.05.2016Application deemed to be withdrawnpublished on 15.06.2016  [2016/24]
Applicant(s)For all designated states
Gachon University of Industry-Academic Cooperation Foundation
1342 Seongnam-daero
Sujeong-gu
Seongnam-si, Gyeonggi-do 461-701 / KR
[2014/42]
Inventor(s)01 / PARK, Sang Chul
369-16 Gungnae-dong
Bundang-gu
Seongnam-si Gyeonggi-do 463-470 / KR
02 / CHO, Sung Chun
702 Daelim A1 Apt.
104-22 Bupyeong-dong
Bupyeong-gu
Incheon 403-010 / KR
03 / SON, Young Hoon
171 Bulgwang 2-dong
Eunpyeong-gu
Seoul 122-853 / KR
04 / LEE, Seok Jin
202 129-36 Dongsung-dong
Jongno-gu
Seoul 110-809 / KR
05 / CHUNG, Sun Gun
15-164 Seongbuk-dong
Seongbuk-gu
Seoul 136-020 / KR
 [2014/42]
Representative(s)Ström & Gulliksson AB
P.O. Box 4188
203 13 Malmö / SE
[N/P]
Former [2014/42]Ström & Gulliksson AB
P.O. Box 4188
203 13 Malmö / SE
Application number, filing date12854772.607.12.2012
WO2012KR10648
Priority number, dateKR2011013060807.12.2011         Original published format: KR 20110130608
[2014/42]
Filing languageKO
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013085352
Date:13.06.2013
Language:KO
[2013/24]
Type: A1 Application with search report 
No.:EP2789332
Date:15.10.2014
Language:EN
[2014/42]
Search report(s)International search report - published on:KR13.06.2013
(Supplementary) European search report - dispatched on:EP30.04.2015
ClassificationIPC:A61K31/136, A61P19/10, A61P43/00
[2015/22]
CPC:
A61K31/136 (EP,KR,US); A61K31/145 (US); A23L33/10 (EP,US);
A61K31/18 (KR); A61P19/00 (EP); A61P19/08 (EP);
A61P19/10 (EP); A61P43/00 (EP); A23V2002/00 (EP,US) (-)
C-Set:
A23V2002/00, A23V2200/306 (EP,US)
Former IPC [2014/42]A61K31/136, A61K31/18, A61P19/10, A61P19/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/42]
TitleGerman:PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT DIAMINODIPHENYLSULFON ODER PHARMAZEUTISCH AKZEPTABLEN SALZE ZUR PRÄVENTION ODER BEHANDLUNG VON ERKRANKUNGEN IN ZUSAMMENHANG MIT DER ABNAHME DER KNOCHENMASSE[2014/42]
English:PHARMACEUTICAL COMPOSITION COMPRISING DIAMINODIPHENYLSULFONE OR THE PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH DECREASE IN BONE MASS[2014/42]
French:COMPOSITION PHARMACEUTIQUE COMPRENANT UNE DIAMINODIPHÉNYLSULFONE OU SES SELS PHARMACEUTIQUEMENT ACCEPTABLES ET PERMETTANT DE PRÉVENIR OU DE TRAITER DES MALADIES ASSOCIÉES À UNE RÉDUCTION DE LA MASSE OSSEUSE[2014/42]
Entry into regional phase27.06.2014Translation filed 
27.06.2014National basic fee paid 
27.06.2014Search fee paid 
27.06.2014Designation fee(s) paid 
27.06.2014Examination fee paid 
Examination procedure27.06.2014Amendment by applicant (claims and/or description)
27.06.2014Examination requested  [2014/42]
01.12.2015Application deemed to be withdrawn, date of legal effect  [2016/24]
12.01.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2016/24]
Fees paidRenewal fee
09.12.2014Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
31.12.201504   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]  - B BERLOW ET AL, "The effect of dapsone in steroid-dependent asthma", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, (19910301), vol. 87, no. 3, doi:10.1016/0091-6749(91)90393-3, ISSN 0091-6749, pages 710 - 715, XP055105107 [A] 1-8 * the whole document *

DOI:   http://dx.doi.org/10.1016/0091-6749(91)90393-3
 [A]  - G BORMANN ET AL, "Dapsone in rosacea fulminans", JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, (20010901), vol. 15, no. 5, doi:10.1046/j.1468-3083.2001.00325.x, ISSN 0926-9959, pages 465 - 467, XP055032411 [A] 1-8 * the whole document *

DOI:   http://dx.doi.org/10.1046/j.1468-3083.2001.00325.x
 [T]  - WOZEL GOTTFRIED ET AL, "Dapsone in dermatology and beyond", ARCHIVES OF DERMATOLOGICAL RESEARCH, SPRINGER, INTERNATIONAL, BERLIN, DE, vol. 306, no. 2, doi:10.1007/S00403-013-1409-7, ISSN 0340-3696, (20131206), pages 103 - 124, (20131206), XP035329209 [T] 1-8 * the whole document *

DOI:   http://dx.doi.org/10.1007/s00403-013-1409-7
International search[A]US6071543  (THORNFELDT CARL R [US]);
 [A]US2005186156  (OSBORNE DAVID W [US]);
 [A]US2007122435  (OSBORNE DAVID W [US]);
 [A]US2008076829  (DALTON JAMES T [US], et al);
 [A]KR20110049808  (SNU R&DB FOUNDATION [KR])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.